Related references
Note: Only part of the references are listed.Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas
Tuyu Zheng et al.
CANCER DISCOVERY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology
Marco Gessi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin
Prit Benny Malgulwar et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling
Dominique Figarella-Branger et al.
NEURO-ONCOLOGY (2016)
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma
Matthew Parker et al.
NATURE (2014)